Company Overview
Snapshot
Founded in April 1996, novoGi operates with 1–10 employees. The company has raised $18.5M across one funding round from 6 investors. In December 2012, novoGi acquired an exclusive license to brand and market a next-generation GI endoscopic video processing standalone solution.
Business overview
novoGi specializes in providing solutions for gastrointestinal (GI) disease management within the Health Tech & Life Sciences sector. The company's core technology utilizes proprietary nitinol-based elements to facilitate natural healing with tissue-sparing, uniform BioDynamix anastomosis. Its product line is designed to press together the ends of resected tissue, enabling natural reconnection of the intestine after surgical removal, primarily for treatments such as colon cancer. novoGi serves the healthcare industry, specifically targeting providers in the Medical Devices and Medical Treatment & Therapeutics categories.
Strategic signal
In March 2014, novoGi underwent a significant downsizing, as reported by Globes. This operational adjustment indicates a strategic recalibration within the company, potentially reflecting market challenges or a shift in its business model. For investors, this signals a period of restructuring and a need to evaluate the company's revised operational efficiency and strategic direction.
Log in to access full profile ›Company Intelligence Q&A
- What is novoGi's primary focus?
- novoGi focuses on providing a range of solutions for gastrointestinal (GI) disease management, utilizing proprietary technology for tissue-sparing BioDynamix anastomosis.
- When was novoGi founded?
- novoGi was founded in April 1996.
- What significant licensing agreement did novoGi secure?
- In December 2012, novoGi acquired an exclusive license to brand and market a next-generation GI endoscopic video processing standalone solution.
- What was a notable operational change for novoGi in 2014?
- In March 2014, novoGi underwent a downsizing of its operations.
- Which investors participated in novoGi's funding round?
- novoGi received funding from investors including Evergreen Venture Partners and Israel HealthCare Ventures.